Gifu, Japan

Naritaka Tamaoki

This inventor holds 1 USPTO granted patent. Top assignees: Gifu University, National Institute of Advanced Industrial Science and Technology. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naritaka Tamaoki. Retrieved from https://idiyas.com/inventor/naritaka-tamaoki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naritaka Tamaoki: Innovator in Stem Cell Research

Introduction

Naritaka Tamaoki is a prominent inventor based in Gifu, Japan. He is known for his significant contributions to the field of stem cell research, particularly in the development of induced pluripotent stem cells (iPS cells). His innovative methods have the potential to revolutionize regenerative medicine and therapeutic applications.

Latest Patents

Tamaoki holds a patent for a method for producing induced pluripotent stem cells. This method involves bringing a nuclear reprogramming substance, specifically the DLX4 gene, OCT3/4 gene, and SOX2 gene, into contact with a cell to produce iPS cells. This groundbreaking work has garnered attention for its implications in medical research and treatment.

Career Highlights

Throughout his career, Tamaoki has been associated with esteemed institutions such as Gifu University and the National Institute of Advanced Industrial Science and Technology. His work at these organizations has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Tamaoki has worked alongside notable colleagues, including Kenichi Tezuka and Kazuki Iida. Their collaborative efforts have contributed to the advancement of knowledge in stem cell technology and its applications.

Conclusion

Naritaka Tamaoki's innovative work in the field of stem cell research highlights his role as a key inventor in this area. His patented method for producing iPS cells represents a significant advancement in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…